Protagenic Therapeutics, Inc.\new (PTIX) Operating income 2015–2024
Protagenic Therapeutics, Inc.\new (PTIX) annual operating income history from SEC filings — each fiscal year as reported.
-$5.7MFY2024 · since FY2015: -$1.0M → -$5.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$5.7M | -25.9% |
| FY2023 | -$4.5M | -27.2% |
| FY2022 | -$3.6M | +14.1% |
| FY2021 | -$4.1M | -62.3% |
| FY2020 | -$2.6M | -22.3% |
| FY2019 | -$2.1M | +9.9% |
| FY2018 | -$2.3M | +2.2% |
| FY2017 | -$2.4M | -5.9% |
| FY2016 | -$2.2M | -117.9% |
| FY2015 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice